Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma.
Moussab DamlajKhadega A AbuelgasimAyman AlhejaziBader AlahmariAhmed S Al AskarMohsen AlzahraniPublished in: Bone marrow transplantation (2020)